Obvious Ventures, True Ventures and Kittyhawk Ventures led a $60m round in MycoMedica, a company focused on developing and delivering fungi-based therapeutic drugs. “This is an exciting step on a lifelong journey to expand knowledge and unlock the healing potential of fungi, and we are grateful for the support from this outstanding group of funders who share our vision and values to help people live healthier, better lives,” Paul Stamets, MycoMedica CEO and Founder.